10x Genomics, a leader in single cell and spatial biology, announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conferen...
clock.bio, a company focused on rejuvenation biology, has appointed Dr. Michael Boehler as Chief Business Officer. Boehler, formerly with BioNTech,...
The pharmaceutical industry has experienced significant executive changes in July 2025, with several companies appointing new leaders to drive stra...
PurpleLab Managed Services is offering solutions to streamline clinical trial development by leveraging real-world data and advanced analytics. The...
clock.bio has appointed Dr. Michael Boehler, a former BioNTech executive, as Chief Business Officer. Boehler will lead the company's business devel...
PurpleLab is addressing industry-wide challenges in clinical trial development through its Managed Services, which leverage comprehensive real-worl...
Hok Hei Tam, Co-founder and Chief Technology Officer at Montai Therapeutics, is spearheading technical discovery efforts to address unmet needs in ...
A new facility dedicated to advancing RNA therapies has been established in Darlington, UK, with nearly £30 million in government funding. This fac...
Genentech, part of the Roche Group, has commenced construction on a new manufacturing facility in Holly Springs, North Carolina. The $700 million p...
Scribe Therapeutics, a genetic medicines company, is set to participate in several major medical, scientific, and investor conferences throughout S...